Tekla Life Valuation
| HQL Stock | USD 13.14 0.12 0.92% |
At this time, the company appears to be fairly valued. Tekla Life Sciences has a current Real Value of $13.22 per share. The regular price of the company is $13.14. Our model measures the value of Tekla Life Sciences from inspecting the company fundamentals such as Operating Margin of (0.66) %, shares outstanding of 28.06 M, and Return On Equity of 0.0128 as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Tekla Life's valuation include:
Price Book 0.7948 | Enterprise Value | Price Sales 91.7992 | Trailing PE 4.2829 | Enterprise Value Revenue 4.2148 |
Fairly Valued
Today
Please note that Tekla Life's price fluctuation is very steady at this time. Calculation of the real value of Tekla Life Sciences is based on 3 months time horizon. Increasing Tekla Life's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Tekla stock is determined by what a typical buyer is willing to pay for full or partial control of Tekla Life Sciences. Since Tekla Life is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Tekla Stock. However, Tekla Life's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 13.14 | Real 13.22 | Hype 13.14 | Naive 13.23 |
The intrinsic value of Tekla Life's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Tekla Life's stock price.
Estimating the potential upside or downside of Tekla Life Sciences helps investors to forecast how Tekla stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Tekla Life more accurately as focusing exclusively on Tekla Life's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Tekla Life's intrinsic value based on its ongoing forecasts of Tekla Life's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Tekla Life's closest peers.
Tekla Life Cash |
|
Tekla Valuation Trend
Knowing Tekla Life's actual value is paramount for traders when making sound investment determinations. Using both Tekla Life's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Tekla Life Total Value Analysis
Tekla Life Sciences is currently projected to have company total value of 365.36 M with market capitalization of 365.36 M, debt of 888.61 K, and cash on hands of 292.4 K. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Tekla Life fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
365.36 M | 365.36 M | 888.61 K | 292.4 K |
Tekla Life Investor Information
About 34.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 0.79. Some equities with similar Price to Book (P/B) outperform the market in the long run. Tekla Life Sciences last dividend was issued on the 21st of February 2025. Based on the measurements of operating efficiency obtained from Tekla Life's historical financial statements, Tekla Life Sciences is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in April.Tekla Life Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of Tekla suggests not a very effective usage of assets in March.Tekla Life Ownership Allocation
Tekla Life Sciences shows a total of 28.06 Million outstanding shares. 30% of Tekla Life Sciences outstanding shares are owned by institutional holders. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that on November 3, 2022, Senator Thomas R Carper of US Senate acquired under $15k worth of Tekla Life Sciences's common stock.Tekla Life Profitability Analysis
The company reported the last year's revenue of 86.69 M. Total Income to common stockholders was 85.3 M with profit before taxes, overhead, and interest of 3.98 M.Tekla Life Past Distributions to stockholders
About Tekla Life Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Tekla Life Sciences. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Tekla Life Sciences based exclusively on its fundamental and basic technical indicators. By analyzing Tekla Life's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Tekla Life's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Tekla Life. We calculate exposure to Tekla Life's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Tekla Life's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 99.7 M | 104.7 M | |
| Pretax Profit Margin | 1.13 | 1.07 | |
| Operating Profit Margin | (0.20) | (0.21) | |
| Net Profit Margin | 1.13 | 1.07 | |
| Gross Profit Margin | 0.70 | 0.73 |
A single share of Tekla Life represents a small ownership stake in the entity. As a stockholder of Tekla, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Tekla Life Dividends Analysis For Valuation
The value of Dividends Paid is estimated to slide to about 9 M. The value of Dividend Yield is estimated to slide to 0.000036. At this time, Tekla Life's Retained Earnings are quite stable compared to the past year. Earnings Yield is expected to rise to 0.19 this year, although the value of Price Earnings Ratio will most likely fall to 4.17.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 16.1 M | 9 M | |
| Dividend Paid And Capex Coverage Ratio | (3.39) | (3.22) |
There are various types of dividends Tekla Life can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Tekla shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Tekla Life Sciences directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Tekla pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Tekla Life by the value of the dividends paid out.
Tekla Life Growth Indicators
Investing in growth stocks can be very risky. If the company such as Tekla Life does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 28.1 M | |
| Quarterly Earnings Growth Y O Y | 0.425 |
Tekla Life Current Valuation Indicators
Tekla Life's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Tekla Life's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Tekla Life, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Tekla Life's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Tekla Life's worth.When determining whether Tekla Life Sciences is a strong investment it is important to analyze Tekla Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Tekla Life's future performance. For an informed investment choice regarding Tekla Stock, refer to the following important reports: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Tekla Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Life. If investors know Tekla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tekla Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.425 | Dividend Share 1.66 | Earnings Share 3.04 | Revenue Per Share | Quarterly Revenue Growth 0.07 |
The market value of Tekla Life Sciences is measured differently than its book value, which is the value of Tekla that is recorded on the company's balance sheet. Investors also form their own opinion of Tekla Life's value that differs from its market value or its book value, called intrinsic value, which is Tekla Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tekla Life's market value can be influenced by many factors that don't directly affect Tekla Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tekla Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.